Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-056567
Filing Date
2025-06-04
Accepted
2025-06-04 21:08:12
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517191-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517191-8_4seq1.xml 4 4377
  Complete submission text file 0001104659-25-056567.txt   5816
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
SCANGOS GEORGE A (Reporting) CIK: 0001202102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37625 | Film No.: 251024857

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Issuer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)